Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3978257 | Brachytherapy | 2007 | 6 Pages |
Abstract
Implantation of the SV using a real-time intraoperative approach is technically feasible and results in higher doses to the SV than has been reported with implantation of the prostate alone. Although dose distribution in the SV can be variable and unpredictable, these doses, in combination with 45Â Gy of EBRT, may be adequate to control disease spread in these organs.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Alice Y. Ho, Ryan J. Burri, Glenn T. Jennings, Nelson N. Stone, Jamie A. Cesaretti, Richard G. Stock,